ALB vs FBLG · rev $1.74B vs $24.0M cap
Albemarle Corp (ALB) versus FibroBiologics, Inc. Common Stock (FBLG) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
FBLG does not have a complete income-statement cache yet.
ALB currently screens at market cap $8.00B. FBLG currently screens at market cap $24.0M.
Not investment advice. Open the ALB and FBLG stock pages for the full models.
Not investment advice.